Executive Team｜Sawai Group Holdings

Directors

Representative Director, Chairman and President, Group Chief Executive Officer and Group Chief Operating Officer

Date of birth:
September 28, 1956
April 1982:
Joined Kyowa Hakko Kogyo Co., Ltd. (currently Kyowa Kirin Co., Ltd.)
January 1989:
Joined Sawai Pharmaceutical Co., Ltd.
June 2000:
Director, Deputy Vice President of Sales Division, and General Manager of Sales Planning Department
June 2002:
Managing Director, Deputy Vice President of Sales Division, and General Manager of Sales Planning Department
June 2005:
Senior Managing Director, Vice President of Sales Division
June 2008:
Representative Director, President
June 2020:
Representative Director, Chairman (incumbent)
April 2021:
Representative Director, Chairman of the Company
June 2023:
Representative Director, Chairman and President of the Company (incumbent)

Director, Senior Managing Executive Officer, and Group Chief Research & Development Officer

Date of birth:
July 22, 1957
April 1982:
Joined Yamanouchi Pharmaceutical Co., Ltd. (currently Astellas Pharma Inc.)
September 2016:
Joined Sawai Pharmaceutical Co., Ltd.
June 2017:
Corporate Officer, and Deputy Vice President of Research & Development Division, and Director of Analytical Chemistry Department
June 2019:
Senior Executive Officer, and Vice President of Research & Development Division
April 2021:
Director, Senior Executive Officer, and Vice President of Research & Development Division
Managing Executive Officer of the Company
June 2023:
Director, Senior Managing Executive Officer of the Company (incumbent)
Director, Senior Managing Executive Officer of Sawai Pharmaceutical Co., Ltd. (incumbent)

External Director

Date of birth:
April 25, 1951
April 1979:
Registered as a lawyer at Osaka Bar Association
Joined Kikkawa Sogo Law Offices (currently Kikkawa Law Offices)
February 1987:
Attorney registered in the State of New York, the U.S.
January 1988:
Partner of Kikkawa Law Offices (incumbent)
April 2004:
Member of the Board of Directors for the Kinki Federation of Bar Associations
April 2017:
The President of Osaka Bar Association, the Vice President of Japan Federation of Bar Associations
June 2019:
Director of Sawai Pharmaceutical Co., Ltd.
April 2021:
Director of the Company (incumbent)
September 2022:
External Auditor of Shibuya Corporation (incumbent)
June 2023:
External Director of Atsugi Co., Ltd. (incumbent)

External Director

Date of birth:
October 30, 1954
April 1982:
Joined Mitsubishi Chemical Industries (currently Mitsubishi Chemical Corporation)
June 2009:
Board Director, Executive Officer, General Manager of Global Product Strategy Department of Mitsubishi Tanabe Pharma Corporation
April 2012:
Board Director, Managing Executive Officer, Division Manager of Development Division
April 2014:
Representative Director, Senior Managing Executive Officer
June 2014:
President & Representative Director, Chief Executive Officer
April 2020:
Board Director
June 2020:
Advisor
June 2023:
Director of the Company (incumbent)

External Director

Date of birth:
September 25, 1973
April 1996:
Joined Kanebo Ltd., assigned to the R&D Center, Pharmaceutical Business Department
April 1998:
Joined Nihon Schering K.K. (currently Bayer Yakuhin, Ltd.), assigned to the Clinical Development Department
June 2004:
Diagnostic Pharmaceutical Development Department Manager, Clinical Development Department, Nihon Schering K.K
April 2010:
Manager, Diagnostic Pharmaceutical/Gynecology Development Department, Bayer Yakuhin, Ltd.
January 2012:
Medical Information Manager, Medical Affairs Department, Bayer Yakuhin, Ltd.
January 2014:
Market Access Department Active Manager, Bayer Yakuhin, Ltd.
January 2015:
Market Access Manager, Executive Officer, Bayer Yakuhin, Ltd.
February 2024:
Established Tomo Value Healthcare Solutions (incumbent)
June 2025:
Director of the Company (incumbent)

Director, Audit & Supervisory Committee Member

July 2008:
Joined Sawai Pharmaceutical Co., Ltd.; General Manager, Controller Department
April 2012:
General Manager, General Affairs Department
June 2018:
Full-time Audit & Supervisory Board Member
April 2021:
Full-time Audit & Supervisory Board Member of the Company and Audit & Supervisory Board Member of Sawai Pharmaceutical (incumbent)
June 2025:
Director, Audit & Supervisory Committee Member of the Company (incumbent)

External Director, Audit & Supervisory Committee Member

Date of birth:
July 8, 1964
October 1990:
Joined Asahi Shinwa & Co. (currently KPMG AZSA LLC)
May 1994:
Registered as a certified public accountant
June 2011:
Partner at KPMG AZSA LLC
June 2019:
Resigned from KPMG AZSA LLC
July 2019:
Representative, Etsuko Taniguchi CPA Office (incumbent)
June 2021:
Outside Director of TATSUTA Electric Wire and Cable Co., Ltd. (Audit & Supervisory Committee Member)
June 2025:
Director, Audit & Supervisory Committee Member of the Company (incumbent)

External Director, Audit & Supervisory Committee Member

Date of birth:
November 16, 1963
May 1988:
Physician’s License (Qualification acquired and registered)
June 1997:
Master’s Degree, Harvard School of Public Health
September 1997:
Medical Officer, World Health Organization, Headquarters, Geneva
April 2003:
Planning Advisor, Joint United Nation’s Programme on HIV/AIDS, Headquarters, Geneva
January 2005:
Chief Technical Advisor, International Labour Organization, Africa
May 2008:
Chief Executive Officer, Digital Plaza Co., USA
March 2020:
President, Management Consultants for CEOs (incumbent)
April 2023:
Certified Management Consultant (Qualification acquired and registered)
June 2025:
Director, Audit & Supervisory Committee Member of the Company (incumbent)